Background-Sudden cardiac arrest (SCA) is a major contributor to mortality, but data are limited among nonwhites.
S
udden cardiac arrest (SCA) is a major cause of mortality in the United States, contributing to 300 000 to 350 000 sudden cardiac deaths (SCDs) annually and accounting for 50% of all cardiovascular mortality. 1 However, there is little information on SCA in nonwhite racial groups. US studies published 2 to 3 decades ago estimated SCA incidence by race, and all reported a significantly higher incidence in blacks compared with whites. [2] [3] [4] [5] [6] However, differences by race in the clinical profile of SCA cases have not been evaluated. In addition, these studies used single sources of ascertainment, which can lead to underascertainment or misclassification. For example, the use of only the emergency medical response system as a source misses 30% to 40% of all SCA subjects that do not undergo resuscitation. 7 Most important, the majority of previous studies, especially those evaluating larger numbers of subjects, determined SCD from death certificates, now shown to have significant limitations compared with prospective community-based ascertainment. 7, 8 
Clinical Perspective on p 387
Our objective was to compare medical history among SCA cases by race using a prospective, multiple-source, populationbased approach, the Oregon Sudden Unexpected Death Study (Oregon SUDS). This study, ongoing since 2002, collects detailed information on cardiac arrest circumstances and lifetime medical history.
Methods

Study Population
The Oregon SUDS is an ongoing community-based epidemiological study that uses multiple-source ascertainment to identify cases of outof-hospital cardiac arrest occurring in the Portland, OR, metropolitan region, including Portland's Multnomah County. Methods for this study have previously been published. 7, 9 Briefly, cases are identified prospectively through collaboration with the region's 2-tiered emergency medical services (EMS) system, the state medical examiner's office, and the 16 hospitals in the region.
For the period or February 1, 2002, through January 31, 2005, the burden assessment period, all patients with an out-of-hospital cardiac arrest in Multnomah County were prospectively identified for potential inclusion in Oregon SUDS, including all cases with EMS response regardless of outcome, patients without EMS response who were found deceased and reported directly to the medical examiner, and a small proportion who experienced SCA in hospital emergency rooms. To identify cases missed during prospective reporting, we performed periodic retrospective review of electronic EMS records using preselected key words, as well as periodic reviews of all nontraumatic sudden deaths identified by the medical examiner, with the goal of identifying all potential cases of out-of-hospital SCA in the county. Cases included deceased subjects and survivors of SCA. Data from the burden assessment phase of the Oregon SUDS were used to calculate incidence rates. Since February 1, 2005, case ascertainment has been limited to the subset of cases with a blood sample collected during attempted resuscitation by EMS or after survival from SCA or with a tissue sample collected during autopsy. Collection of data on arrest circumstances, outcomes, and prearrest medical history remained consistent throughout the Oregon SUDS study period.
This study was approved by the institutional review boards of Cedars-Sinai Medical Center, Oregon Health and Science University, and all participating hospital systems.
Definition and Adjudication of SCA
All identified potential cases of SCA were then subjected to detailed adjudication for determination of SCA. All existing records were obtained for each case, including the EMS prehospital care report, the patient's complete medical records from the hospitals in the region (including records from the index SCA event and pre-SCA clinical history), death certificates from Oregon State vital statistics records, and the medical examiner report and autopsy if available. Using this detailed information, 3 physicians performed in-house adjudication for determination of SCA, which was defined as a sudden, unexpected pulseless condition of likely cardiac origin 1 ; individuals with unwitnessed arrests were required to have been seen in normal health within 24 hours of arrest. All individuals deemed to have a noncardiac cause for cardiac arrest such as trauma, drug overdose, and chronic terminal illness (eg, on home oxygen or malignancy not in remission) were excluded. Approximately one quarter of initially identified cases did not meet prespecified criteria and were excluded during the adjudication process. A comparison of the method of case ascertainment and adjudication used in Oregon SUDS with SCD determined by death certificates during the first year of the study (353 cases) revealed that the Oregon SUDS method was significantly more specific and complete. 
Patient Demographics and Medical History
Definition of Race
Race data for individual cases were obtained from death certificates, medical examiner reports, medical records, and EMS prehospital care reports and were available for 96% of all individuals experiencing SCA who were ≥18 years of age in Multnomah County from 2002 to 2012 and for >99% of individuals with medical records before arrest. US Census data were used for the race/ethnic composition of the community. 10 Race was categorized as white, black, Hispanic, Asian, and other. Hispanic included any individual reporting Hispanic ethnicity, regardless of race. "Other" included American Indian/Alaska Native and Hawaiian/Pacific Islander.
Medical History
Circumstances of the cardiac arrest event were obtained from the EMS prehospital care report and characterized with the Utstein template. 11 To determine the outcome of arrest for each patient, we review the EMS report or medical examiner report and all available hospital records and search Oregon death certificate records for all cases. If vital status still remains uncertain, we also search the national Social Security Death Index. Individuals are placed in an unknown survival category only after this extensive search.
From the patient's complete medical records, documented coronary artery disease was defined as ≥50% stenosis on a prearrest angiogram or a documented history of myocardial infarction or revascularization. Body mass index was determined by height (cm) divided by the weight (kg) squared, with obesity defined as body mass index ≥30 kg/m 2 . Diabetes mellitus was defined as a chart history of diabetes mellitus or use of insulin or oral hypoglycemic agents; chronic renal insufficiency, by a chart history of renal failure or hemodialysis; and hypertension and congestive heart failure, by chart history. Medication use before arrest was noted in the medical record closest to the date of arrest.
For the subset of cases with prearrest or periarrest angiograms, we obtained information on quantitative stenosis of coronary arteries. For the subset with prearrest ECGs available, heart rate and QRS were obtained from the computer-read values on the 12-lead ECG; the QT interval was manually read with digital on-screen software (DatInf Measure, DataInf GmbH, Tübingen, Germany). Left ventricular hypertrophy (LVH) by ECG was diagnosed if Sokolow-Lyon criteria (S V 1 +R V 5 or V 6 ≥35 mm) 12 or Cornell voltage criteria (S in V 3 +R in aVL>28 mm in men and 20 mm in women) were met. For the subset of patients with echocardiograms, we obtained ejection fraction and considered LVH present if left ventricular mass indexed to body surface area was >115 g/m 2 in men or >95 g/m 2 in women. 13 For the subset of SCA cases with autopsy (16.2% of total cases, including cases that occurred outside of Multnomah County to maximize sample size), we examined the following data from the medical examiner's autopsy report: evidence of recent or old infarction; coronary evaluation and quantification of stenosis; heart weight; and cardiac conditions, including hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, aortic stenosis, myocarditis, congenital heart disease, and coronary anomalies. Consistent with our case definition, any suspected SCA case was excluded if there was a nonarrhythmic cause of death (eg, cardiac tamponade, pulmonary embolism) or if toxicology findings revealed illicit drug use.
Statistical Analysis
Clinical Characteristics by Race were included if they were of white or black race and had prearrest medical history available from physician records. Circumstances and outcomes of arrest were evaluated among subjects ≥18 years of age from Multnomah County from February 1, 2002, through January 31, 2012, if they were of white or black race with resuscitation attempted by EMS personnel. All comparisons in whites versus blacks used independent samples t tests and χ 2 tests. Multiple logistic regression was used to test whether survival to hospital discharge was associated with race with adjustment for covariates.
Calculation of SCA Incidence Rates
Age-specific and age-adjusted incidence rates were calculated for whites and blacks using data from the burden assessment period of Oregon SUDS in Multnomah County (February 1, 2002-January 31, 2005; n=106 blacks and 971 whites, including all ages; Figure 1 ). For age-specific rates, the number of cases in each age category made up the numerator (age <1, 1-4, 5-9 years, then by 5-year categories to ≥85 years), and race-and age-specific US Census 2003 intercensal population estimates for Multnomah County made up the denominator; 95% confidence intervals (CIs) for age-specific rates were calculated with the assumption that rates were the approximate mean of a Poisson distribution.
14 Age-adjusted rates were estimated by direct standardization with the US Census 2000 standard population as the adjustment weight, 15 and 95% CIs were estimated according to the gamma distribution method. 16 
Results
Overall Distribution of Race
A total of 2144 cases of SCD (36% women) were identified in Multnomah County, Oregon, from February 1, 2002, through January 31, 2012. Race was available for 2069 (96.5% of total cases): 1745 (84.9%) were white, 179 (8.4%) were black, and 145 (7.0%) were other races. All subsequent comparisons were limited to whites and blacks, given the small numbers in the other groups ( Figure 1 ).
Incidence Rates of SCA by Race, 2002 to 2005
Figure 2 shows age-specific incidence rates by race. Differences were apparent in both men and women across the age spectrum, with rates among blacks higher than among whites in all age categories. Age-adjusted incidence of SCA was 2-fold higher in black men (175 per 100 000; 95% CI, 101-291) compared with white men (84 per 100 000; 95% CI, 73-97). Although absolute rates were lower in women, a 2-fold higher rate was also observed when black women (90 per 100 000; 95% CI, 48-150) were compared with white women (40 per 100 000; 95% CI, 33-48).
Circumstances and Outcomes of Arrest by Race
All subjects ≥18 years of age with resuscitation attempted were included in the analyses of the circumstances and outcomes of SCA (Table 1) . A similar proportion of both black and white subjects had resuscitation attempted: 130 of 171 black subjects (76%) and 1288 of 1730 white subjects (75%). Blacks were younger at the time of SCA than whites (61.0±16.2 versus 67.2±15.6 years; P<0.0001), and significantly more were <65 years of age (58% versus 43%; P=0.002).
Apart from the age difference, no other significant differences were noted in the circumstances of cardiac arrest, including the proportion of witnessed arrests, arrest location, bystander cardiopulmonary resuscitation, response time, and initial arrhythmia (P≥0.29; Table 1 ). Outcomes were slightly worse among blacks, but differences were not significant (return of spontaneous circulation in the field was 39% in whites and 32% in blacks, 
Clinical Profile Before Arrest by Race
Among incident cases of SCA in Multnomah County from 2002 to 2012, 1262 of 1730 whites (73.0%) and 126 of 171 blacks (73.7%) had physician records available to ascertain medical history before arrest. The majority of both black and white subjects had their last medical encounter, ECG, and echocardiogram within 2 years of the date of arrest, and there were no significant differences in the time elapsed (P≥0.58). In this subset (Table 2 ), the age difference between whites and blacks was similar to that in the resuscitated subset (61.2±15.8 years in blacks, 68.1±15.6 years in whites; P<0.0001). Diabetes mellitus was significantly more prevalent among blacks than whites (52% versus 33%; P<0.0001). Hypertension was also more common among black than white subjects with SCA (77% versus 65%; P=0.006), as was chronic renal insufficiency (34% versus 19%; P<0.0001). Other clinical comparisons revealed no black-white differences (obesity, hyperlipidemia, peripheral vascular disease, cerebrovascular disease, current smoking, chronic obstructive pulmonary disease, liver disease, depression, and dementia; P≥0.13).
Cardiac History
Blacks were as likely as whites to have had a clinically recognized history of coronary artery disease and myocardial infarction (Table 3) . Whites were somewhat more likely to have had a coronary artery revascularization before cardiac arrest, whereas blacks had a higher prevalence of prearrest congestive heart failure (43% versus 34%; P=0.04). In the subset of patients with a prearrest or periarrest angiogram (18% of subjects), blacks were slightly but nonsignificantly less likely to have findings of significant coronary artery disease (≥50% stenosis in ≥1 coronary artery; P=0.10). Among the 50% of subjects with prearrest ECGs (Table 3) , the Bazett heart ratecorrected QT interval was significantly longer among blacks (QTc, 466±36 versus 453±41 milliseconds; P=0.03), and LVH by ECG criteria was more common among blacks (24% versus 13%; P=0.008). Heart rate and QRS duration were similar by race. Finally, in the 33% of subjects with a prearrest echocardiogram (Table 3) , LVH by echocardiographic criteria was highly prevalent and significantly more common among blacks compared with whites (77% versus 58%; P=0.02), and left ventricular size was significantly greater (P=0.02). No racial differences in ejection fraction were observed.
Medication Use by Race
Use of medications to treat cardiovascular risk factors was common among both white and black patients who went on to have SCA (Table 4) . Among patients with diabetes mellitus, there was no racial difference in the proportion taking antidiabetic medications (P=0.39); among patients with hypertension, there was no racial difference in the proportion taking angiotensinconverting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, diuretics, or β-blockers (P≥0.13); and among patients with hyperlipidemia, there was no difference in the proportion taking lipid-lowering drugs (P=0.85). Finally, among all patients, white patients were somewhat more likely than blacks to be taking anticoagulants (18% versus 10%; P=0.04); there were no other significant differences by race in the proportion of patients taking β-blockers, statins, lipid-lowering drugs, or antianginal drugs (P≥0.28).
Autopsy Findings by Race
Autopsies were available for 15.7% of blacks (n=30) and 16.2% of whites (n=365) in Oregon SUDS (Table 5) . Findings of fresh myocardial infarction were not significantly different in blacks and whites (13% versus 20%; P=0.38), although blacks were somewhat less likely to have an old infarct identified at autopsy (7% versus 22%; P=0.05). Blacks were also less likely than whites to have significant (≥50%) coronary artery stenosis in at least 1 coronary artery (55% versus 79%; P=0.009). Blacks were more likely to have hypertrophic cardiomyopathy (13% versus 5%; P=0.07). There were no racial differences in the following conditions, all of which had a prevalence of <3%: aortic stenosis, arrhythmogenic All comorbidities are as defined in the text. Because of missing data, sample sizes were smaller for body mass index and obesity (whites, n=840; blacks, n=98) and current smoking (whites, n=834; blacks, n=90). SCA indicates sudden cardiac arrest; and SUDS, Sudden Unexpected Death Study. right ventricular dysplasia, congenital heart disease, coronary anomalies, and myocarditis. No differences were observed in mean heart weight or wall thickness.
Discussion
In this community-based study, the age-adjusted annual incidence of SCA among black men and women (175 and 90 per 100 000, respectively) was more than twice the incidence observed in white men and women (84 and 40 per 100 000, respectively). Blacks were younger at the time of SCA by >6 years and had a higher prevalence of specific cardiovascular risk factors, including a history of diabetes mellitus and hypertension, as well as chronic renal insufficiency. There were no racial differences in the burden of previously documented coronary disease overall or in the subset with coronary angiogram. However, blacks were more likely than whites to have several noncoronary cardiac findings: LVH by ECG and echocardiogram, prolonged QTc interval, and congestive heart failure. Among these community-dwelling patients who experienced SCD, differences in preventive medications did not appear to explain racial disparities in SCD rates. In the subset of cases with autopsy, blacks had less significant coronary stenosis and less evidence of old infarct, but a somewhat higher proportion had hypertrophic cardiomyopathy. Despite the racial differences in incidence and comorbidities that we report, we found no racial differences in the circumstances or outcomes of SCA.
Earlier epidemiological reports, most conducted 2 to 3 decades ago, also noted a higher incidence of SCA among blacks compared with whites. [2] [3] [4] [5] [6] Although our results for SCA burden are consistent with the published literature, the findings related to age, comorbidities, and noncoronary cardiac risk factors are new and likely warrant urgent attention. SCA occurs at a significantly younger age in blacks, with a higher prevalence of clinical risk factors beyond previously documented coronary disease. A black-white disparity in cardiovascular disease risk factor burden and overall cardiovascular mortality is well documented [17] [18] [19] and, our findings indicate, extends to SCA occurrence in the community. Diabetes mellitus is more prevalent among blacks than whites in general, 20, 21 as is hypertension, 17 heart failure, 22 chronic kidney disease, 23 and LVH. 24 Recent data from patients with coronary disease also suggest that the QT interval is prolonged in blacks compared with whites. 25 However, each of these conditions may also be specifically associated with SCA.
26-31 A combination of these risk markers may indicate high risk for SCA even in the absence of severely reduced ejection fraction. In a recent analysis of >4000 participants with heart failure and preserved ejection fraction from the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) trial cohort, a history of diabetes mellitus, myocardial infarction, left bundle-branch block on ECG, and higher N-terminal of the prohormone brain natriuretic peptide were useful in identifying patients with a ≥10% cumulative 5-year risk of SCA. 32 Additional evidence suggests that blacks may have a higher risk specifically for SCA. In the Atherosclerosis Risk in Communities (ARIC) study with >12 years of follow-up, the incidence of SCA among blacks was 2 to 3 times higher than among whites, whereas race differences were smaller or absent for nonsudden cardiovascular death and nonfatal myocardial infarction. 33 Findings from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study also showed a more pronounced black-white difference in fatal coronary heart disease events compared with nonfatal coronary heart disease events, although this difference became nonsignificant after adjustment for cardiovascular disease risk factor burden. 34 It is plausible that genetic variation or other as-yet unidentified factors may also contribute to a specific risk for SCA. Our finding that SCA occurred >6 years earlier in blacks may be consistent with a genetic contribution to SCA occurrence in blacks, given existing data showing a strong genetic component in early-onset cardiovascular disease and cardiovascular outcomes.
35-38
Limitations
For incidence rate calculations, county-level census data were used for race-specific population counts. Therefore, although individual-level data on race, medical history, and demographics were available for SCA cases, individual-level analyses to further evaluate the relationship between SCA incidence, race, and comorbidities were not possible. Although the Oregon SUDS includes control subjects, we were not able to include analyses comparing black and white cases to black and white controls because of the small numbers of black control subjects. Therefore, whether the identified risk factors are independently associated with SCA still requires further investigation. Analysis of outcomes was limited to whether the patient survived to hospital discharge. However, this is a standard definition in cardiac arrest research, and the relatively small number of black survivors (n=10) limited our ability to make more detailed comparisons (eg, functional status) in this subgroup.
The number of cases among Hispanics and Asians was relatively small, necessitating a focus on blacks versus whites. Two previous studies in the United States have included SCD incidence in Hispanics. 5, 6 Both reported somewhat lower rates than among whites, but both used death certificate data to determine SCD, which has limitations. 7, 8 To the best of our knowledge, no US study has reported SCA incidence among Asians. However, a review of treated out-of-hospital cardiac arrest around the globe reported the highest rate in North America (54.6/100 000) and the lowest in Asia (28.3/100 000). 39 Therefore, a focus on SCA among all minority groups, including nonblack minority groups, is urgently needed.
Most patients with out-of-hospital SCA do not routinely undergo an autopsy to confirm cause of death. Using our established protocols, we carefully reviewed circumstances of arrest as noted by EMS personnel and adjudicated every case in an attempt to rule out those in which stroke or pulmonary embolism was strongly suspected. However, we cannot exclude the possibility of some misclassification in our case population, especially with regard to stroke among black subjects.
Medical records, including clinical history before SCA, were available for a comparable number of black and white cases (74% and 73%). Some data such as that from ECGs and echocardiograms performed before arrest were available for a sub-group of cases, and consistent with their higher comorbidity profile, obtained for a larger proportion of blacks versus whites. We cannot rule out the possibility of some bias resulting from differential misclassification related to missing clinical data.
Our study is unique in that it included a detailed evaluation of lifetime medical history to examine racial differences in risk factors for SCA. Given the low overall rates of SCA, the cases evaluated in this study represent a sizable population, even blacks, who represented <10% of the overall study population but had a sample size of >100. 
